Clinical trial
Observational Study of Males With Creatine Transporter Deficiency
NCT02931682 is registered in ClinicalTrials.gov with Ultragenyx Pharmaceutical Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Study of Males With Creatine Transporter Deficiency
- Lead sponsor
- Ultragenyx Pharmaceutical Inc
- Phase
- Observational
- Overall status
- Terminated
- Start date
- December 31, 2016
- Completion date
- October 24, 2022
- Enrollment
- 50 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
creatine deficiency, x-linked